Sardine peptide with angiotensin I-converting enzyme inhibitory activity improves glucose tolerance in stroke-prone spontaneously hypertensive rats.
An enzymatic hydrolysate of sardine protein (sardine peptide, SP) derived from sardine muscle possesses angiotensin I-converting enzyme (ACE) inhibitory activity. In the present study, we investigated the effect of SP on the blood glucose levels in stroke-prone spontaneously hypertensive rats (SHRSPs). Ten-week-old SHRSPs were assigned to three groups. The control group was given tap water for 4 weeks, while the experimental groups were given water containing SP (1 g/kg/d) or an ACE inhibitor, captopril (8 mg/kg/d). Treatment with SP and captopril decreased ACE activity in the kidney, aorta, and mesentery. There were no differences in fasting blood glucose levels among the three groups, whereas SP and captopril administration significantly suppressed the increase in blood glucose after glucose loading in the control SHRSPs. No difference was observed in plasma insulin levels among the three groups. Thus treatment with captopril and ACE-inhibitory sardine peptides ameliorated the glucose tolerance of this rat strain.
Otani
Lila
L
Department of Food Science and Nutrition, Faculty of Agriculture, Kinki University, Nara, Japan.
Ninomiya
Toshio
T
Murakami
Megumi
M
Osajima
Katsuhiro
K
Kato
Hisanori
H
Murakami
Tetsuo
T
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002216:Captopril / Q000494:pharmacology; D006332:Cardiomegaly / Q000150:complications; D005399:Fishes; D006943:Hyperglycemia / Q000150:complications; D006973:Hypertension / Q000097:blood / Q000150:complications / Q000473:pathology; D007674:Kidney Diseases / Q000150:complications; D008297:Male; D009929:Organ Size / Q000187:drug effects; D010455:Peptides / Q000494:pharmacology*; D007703:Peptidyl-Dipeptidase A / Q000097:blood / Q000378:metabolism*; D051381:Rats; D011918:Rats, Inbred SHR; D020521:Stroke / Q000150:complications*
D000806:Angiotensin-Converting Enzyme Inhibitors; D001786:Blood Glucose; D010455:Peptides; D002216:Captopril; D007703:Peptidyl-Dipeptidase A